ImmunoPrecise Antibodies Ltd. (IPA) NASDAQ

0.38

-0.0201(-4.96%)

Updated at March 14 04:00PM

Currency In USD

Valuation

Market Cap45.21M
Enterprise Value55.43M
P/E Ratio-0.57
PEG Ratio-0.58
Price/Sales Ratio1.05
Price/Book Ratio0.48
Enterprise/Revenue1.59
Enterprise/EBITDA-4.14

Fiscal Year

Fiscal YearApril 30, 2024
Most Recent QuarterOctober 31, 2024

Profitability

Profit Margin-1.14
Operating Margin-0.55

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.74

Income Statement

Revenue24.52M
Revenue/Share0.86
Gross Profit12.05M
EBITDA-22.95M
Net Income-27.18M
Diluted EPS-1.06

Balance Sheet

Total Cash3.53M
Total Cash/Share0.13
Total Debt16.42M
Total Debt/Equity0.5
Current Ratio1.01
Book Value Per Share1.16

Price History

52-Week Change-73.27
52-Week High1.64
52-Week Low0.27
Moving Average 50 Days0.46
Moving Average 200 Days0.63

Statistics

Average Volume7.88M
Shares Outstanding45.77M
% Held by Institutions6.78

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateNovember 23, 2020